Oct 25 (Reuters) - Gene-sequencing company Pacific BioSciences of California Inc PACB.O on Tuesday announced the launch of a new, more affordable, higher-throughput "long-read" sequencer as well as ...
PacBio (PACB) announced SPRQ, an improved sequencing chemistry for its Revio long-read sequencing system. The new chemistry will reduce Revio DNA input requirements ...
MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its ...
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its first customer shipments of Revio long-read sequencing systems will commence on March 8, 2023. As ...
MENLO PARK, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PacBio (PACB) (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced SPRQ, an improved ...
Aberdeen Proving Ground, MD – Future battlefields require an on-the-go approach to the identification of whatever biological threat our warfighters may come across. One such approach – Far-Forward ...
Single cell sequencing is a powerful technique for revealing hidden complexity within cell populations. The technique has found widespread adoption in fields such as immunology, neuroscience, and ...
Hosted on MSN
Illumina fined $9.8M for selling DNA sequencers with cybersecurity flaws to U.S. agencies
Illumina Inc., a leading biotechnology company, has agreed to pay $9.8 million to settle allegations that it sold genomic sequencing systems with serious cybersecurity flaws to U.S. federal agencies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback